Overexpression of the Rac1-specific GEF, T-cell lymphoma invasion and metastasis 1 (Tiam1), has been reported in highly invasive breast tumours [4] and colon carcinomas [5-8], and may contribute to elevated Rac1 signalling in these cancers. Here, RAC1 is linked to breast neoplasm.